当前位置:首页 - 行情中心 - 百洋医药(301015) - 财务分析

百洋医药

(301015)

  

流通市值:100.17亿  总市值:100.18亿
流通股本:5.26亿   总股本:5.26亿

百洋医药(301015)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.55亿元,每股收益0.24元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益289864.02万元,未分配利润171280.22万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产856787.96万元,负债566923.94万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,783,828,902.37,506,514,889.155,627,105,173.243,751,291,789.24
营业总成本1,584,783,180.556,840,247,859.664,964,392,143.683,428,066,346.85
其他经营收益
营业利润194,034,590.16736,266,227.22706,472,533.66265,699,374.41
利润总额193,581,079.36722,975,024.62695,288,726.28259,969,476.57
净利润155,458,342.19571,929,272.87560,613,786.74211,406,109.96
每股收益
其他综合收益586.44-5,215,824.27-1,351,003.281,354,600.8
综合收益总额155,458,928.63566,713,448.6559,262,783.46212,760,710.76
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计6,114,441,794.155,717,712,971.315,341,242,262.975,023,005,956.92
非流动资产:
非流动资产合计2,453,437,854.792,394,537,014.232,250,194,126.742,136,883,680
资产总计8,567,879,648.948,112,249,985.547,591,436,389.717,159,889,636.92
流动负债:
流动负债合计4,278,362,722.743,977,428,107.963,441,378,304.63,330,990,823.98
非流动负债:
非流动负债合计1,390,876,704.581,392,973,506.621,386,290,913.961,386,127,561.75
负债合计5,669,239,427.325,370,401,614.584,827,669,218.564,717,118,385.73
所有者权益(或股东权益):
归属于母公司股东权益合计2,588,824,336.062,463,146,954.842,481,532,375.262,169,932,617.41
股东权益合计2,898,640,221.622,741,848,370.962,763,767,171.152,442,771,251.19
负债和股东权益合计8,567,879,648.948,112,249,985.547,591,436,389.717,159,889,636.92
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计2,253,961,517.998,439,678,080.916,420,978,563.774,420,362,102.21
经营活动现金流出小计2,231,044,691.387,505,224,476.055,799,560,998.564,028,597,444.81
经营活动产生的现金流量净额22,916,826.61934,453,604.86621,417,565.21391,764,657.4
投资活动产生的现金流量:
投资活动现金流入小计88,066,499.52348,104,559.7236,800,667.34136,069,442.84
投资活动现金流出小计276,003,109.05936,910,315.11766,370,662.08416,772,573.22
投资活动产生的现金流量净额-187,936,609.53-588,805,755.41-529,569,994.74-280,703,130.38
筹资活动产生的现金流量:
筹资活动现金流入小计1,112,016,033.822,487,816,664.512,235,685,474.722,146,682,267.92
筹资活动现金流出小计606,513,344.152,122,337,858.71,892,813,853.791,669,357,786.64
筹资活动产生的现金流量净额505,502,689.67365,478,805.81342,871,620.93477,324,481.28
汇率变动对现金及现金等价物的影响-4,424,046.32-9,730,307.46-6,340,154.17-3,208,683.17
现金及现金等价物净增加额336,058,860.43701,396,347.8428,379,037.23585,177,325.13
期末现金及现金等价物余额2,260,001,402.281,923,942,541.851,650,925,231.281,807,723,519.18
补充资料:
现金及现金等价物的净增加额-701,396,347.8-585,177,325.13
最新报告期:2026-05-20
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华源证券刘闯1.051.241.342026-05-20
华泰证券代雯,孔垂岩,王殷杰1.091.221.352026-05-01
开源证券余汝意,巢舒然1.051.211.392026-04-30
中国银河程培0.971.071.232026-04-29
方正证券许睿,周超泽1.061.501.662026-04-07
TOP↑